Unicycive Therapeutics, Inc.
UNCY
Revenue
675.00k
▼-276.00k▼-29.02%
6 Months ChangeAssets
44.70M
▼-7.68M▼-14.67%
3 Months ChangeLiabilities
13.36M
▼-17.29M▼-56.42%
3 Months ChangeFree Cash Flow
-6.46M
▼-3.50M▼-118.38%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-25
Form 8-K
ID: 0001213900-24-081531
2024-08-14
Form 8-K
ID: 0001213900-24-068597
2024-08-14
Form 10-Q
ID: 0001213900-24-068565
2024-07-15
Form 8-K
ID: 0001213900-24-061355
2024-07-15
Form 8-K
ID: 0001213900-24-061354
2024-07-02
Form 8-K
ID: 0001213900-24-058621
2024-06-26
Form 8-K
ID: 0001213900-24-056224
2024-06-25
Form 8-K
ID: 0001213900-24-055436
2024-06-20
Form 8-K
ID: 0001213900-24-054279
2024-05-13
Form 8-K
ID: 0001213900-24-042338